aTyr Pharma (LIFE) IPO Opens Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
aTyr Pharma, Inc. Announces Pricing of Initial Public Offering
May 6, 2015 8:16 PM EDTSAN DIEGO, May 6, 2015 /PRNewswire/ -- aTyr Pharma, Inc. ("aTyr"), today announced the pricing of its initial public offering of 5,360,000 shares of its common stock at an initial public offering price of $14.00 per share. In addition, aTyr has granted the underwriters a 30-day option to purchase up to an additional 804,000 shares of common stock from aTyr at the initial public offering price, less underwriting discounts and commissions. aTyr's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "LIFE" on May 7, 2015. Closing of... More
